Global AAV Plasmid Market Growth (Status and Outlook) 2024-2030

Publication ID:

LPI10246446

Publication Date:

October 9, 2024

Pages:

103

Publisher:

LPI

Countries:

Global [1]

USD 3,660.00

Manufacturing (Chemicals) [2]

Chemicals [3]

Description:

The global AAV Plasmid market size was valued at US$ million in 2023. With growing demand in downstream market, the AAV Plasmid is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period.
The research report highlights the growth potential of the global AAV Plasmid market. AAV Plasmid are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of AAV Plasmid. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the AAV Plasmid market.
AAV plasmids (adeno-associated virus plasmids) are the primary viral vectors used in in vivo gene therapy clinical trials due to their high efficiency and enhanced safety in humans.
Key Features:
The report on AAV Plasmid market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the AAV Plasmid market. It may include historical data, market segmentation by Type (e.g., AAV Plasmids with C-terminal TGFP Tag, AAV Plasmid with C-terminal TRFP Tag), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the AAV Plasmid market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the AAV Plasmid market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the AAV Plasmid industry. This include advancements in AAV Plasmid technology, AAV Plasmid new entrants, AAV Plasmid new investment, and other innovations that are shaping the future of AAV Plasmid.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the AAV Plasmid market. It includes factors influencing customer ' purchasing decisions, preferences for AAV Plasmid product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the AAV Plasmid market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting AAV Plasmid market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the AAV Plasmid market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the AAV Plasmid industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the AAV Plasmid market.
Market Segmentation:
AAV Plasmid market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Segmentation by type
AAV Plasmids with C-terminal TGFP Tag
AAV Plasmid with C-terminal TRFP Tag
Segmentation by application
Laboratory
Hospital
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
PlasmidFactory GmbH
GeneCopoeia
Thermo Fisher Scientific
OriGene
Takara Bio
Azenta Life Sciences
Sartorius
Aldevron
Omega Bio Tek
Addgene
Viral Vector Core
Azenta
OXGENE

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global AAV Plasmid Market Size 2019-2030
2.1.2 AAV Plasmid Market Size CAGR by Region 2019 VS 2023 VS 2030
2.2 AAV Plasmid Segment by Type
2.2.1 AAV Plasmids with C-terminal TGFP Tag
2.2.2 AAV Plasmid with C-terminal TRFP Tag
2.3 AAV Plasmid Market Size by Type
2.3.1 AAV Plasmid Market Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global AAV Plasmid Market Size Market Share by Type (2019-2024)
2.4 AAV Plasmid Segment by Application
2.4.1 Laboratory
2.4.2 Hospital
2.4.3 Others
2.5 AAV Plasmid Market Size by Application
2.5.1 AAV Plasmid Market Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global AAV Plasmid Market Size Market Share by Application (2019-2024)
3 AAV Plasmid Market Size by Player
3.1 AAV Plasmid Market Size Market Share by Players
3.1.1 Global AAV Plasmid Revenue by Players (2019-2024)
3.1.2 Global AAV Plasmid Revenue Market Share by Players (2019-2024)
3.2 Global AAV Plasmid Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 AAV Plasmid by Regions
4.1 AAV Plasmid Market Size by Regions (2019-2024)
4.2 Americas AAV Plasmid Market Size Growth (2019-2024)
4.3 APAC AAV Plasmid Market Size Growth (2019-2024)
4.4 Europe AAV Plasmid Market Size Growth (2019-2024)
4.5 Middle East & Africa AAV Plasmid Market Size Growth (2019-2024)
5 Americas
5.1 Americas AAV Plasmid Market Size by Country (2019-2024)
5.2 Americas AAV Plasmid Market Size by Type (2019-2024)
5.3 Americas AAV Plasmid Market Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC AAV Plasmid Market Size by Region (2019-2024)
6.2 APAC AAV Plasmid Market Size by Type (2019-2024)
6.3 APAC AAV Plasmid Market Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe AAV Plasmid by Country (2019-2024)
7.2 Europe AAV Plasmid Market Size by Type (2019-2024)
7.3 Europe AAV Plasmid Market Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa AAV Plasmid by Region (2019-2024)
8.2 Middle East & Africa AAV Plasmid Market Size by Type (2019-2024)
8.3 Middle East & Africa AAV Plasmid Market Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global AAV Plasmid Market Forecast
10.1 Global AAV Plasmid Forecast by Regions (2025-2030)
10.1.1 Global AAV Plasmid Forecast by Regions (2025-2030)
10.1.2 Americas AAV Plasmid Forecast
10.1.3 APAC AAV Plasmid Forecast
10.1.4 Europe AAV Plasmid Forecast
10.1.5 Middle East & Africa AAV Plasmid Forecast
10.2 Americas AAV Plasmid Forecast by Country (2025-2030)
10.2.1 United States AAV Plasmid Market Forecast
10.2.2 Canada AAV Plasmid Market Forecast
10.2.3 Mexico AAV Plasmid Market Forecast
10.2.4 Brazil AAV Plasmid Market Forecast
10.3 APAC AAV Plasmid Forecast by Region (2025-2030)
10.3.1 China AAV Plasmid Market Forecast
10.3.2 Japan AAV Plasmid Market Forecast
10.3.3 Korea AAV Plasmid Market Forecast
10.3.4 Southeast Asia AAV Plasmid Market Forecast
10.3.5 India AAV Plasmid Market Forecast
10.3.6 Australia AAV Plasmid Market Forecast
10.4 Europe AAV Plasmid Forecast by Country (2025-2030)
10.4.1 Germany AAV Plasmid Market Forecast
10.4.2 France AAV Plasmid Market Forecast
10.4.3 UK AAV Plasmid Market Forecast
10.4.4 Italy AAV Plasmid Market Forecast
10.4.5 Russia AAV Plasmid Market Forecast
10.5 Middle East & Africa AAV Plasmid Forecast by Region (2025-2030)
10.5.1 Egypt AAV Plasmid Market Forecast
10.5.2 South Africa AAV Plasmid Market Forecast
10.5.3 Israel AAV Plasmid Market Forecast
10.5.4 Turkey AAV Plasmid Market Forecast
10.5.5 GCC Countries AAV Plasmid Market Forecast
10.6 Global AAV Plasmid Forecast by Type (2025-2030)
10.7 Global AAV Plasmid Forecast by Application (2025-2030)

11 Key Players Analysis
11.1 PlasmidFactory GmbH
11.1.1 PlasmidFactory GmbH Company Information
11.1.2 PlasmidFactory GmbH AAV Plasmid Product Offered
11.1.3 PlasmidFactory GmbH AAV Plasmid Revenue, Gross Margin and Market Share (2019-2024)
11.1.4 PlasmidFactory GmbH Main Business Overview
11.1.5 PlasmidFactory GmbH Latest Developments
11.2 GeneCopoeia
11.2.1 GeneCopoeia Company Information
11.2.2 GeneCopoeia AAV Plasmid Product Offered
11.2.3 GeneCopoeia AAV Plasmid Revenue, Gross Margin and Market Share (2019-2024)
11.2.4 GeneCopoeia Main Business Overview
11.2.5 GeneCopoeia Latest Developments
11.3 Thermo Fisher Scientific
11.3.1 Thermo Fisher Scientific Company Information
11.3.2 Thermo Fisher Scientific AAV Plasmid Product Offered
11.3.3 Thermo Fisher Scientific AAV Plasmid Revenue, Gross Margin and Market Share (2019-2024)
11.3.4 Thermo Fisher Scientific Main Business Overview
11.3.5 Thermo Fisher Scientific Latest Developments
11.4 OriGene
11.4.1 OriGene Company Information
11.4.2 OriGene AAV Plasmid Product Offered
11.4.3 OriGene AAV Plasmid Revenue, Gross Margin and Market Share (2019-2024)
11.4.4 OriGene Main Business Overview
11.4.5 OriGene Latest Developments
11.5 Takara Bio
11.5.1 Takara Bio Company Information
11.5.2 Takara Bio AAV Plasmid Product Offered
11.5.3 Takara Bio AAV Plasmid Revenue, Gross Margin and Market Share (2019-2024)
11.5.4 Takara Bio Main Business Overview
11.5.5 Takara Bio Latest Developments
11.6 Azenta Life Sciences
11.6.1 Azenta Life Sciences Company Information
11.6.2 Azenta Life Sciences AAV Plasmid Product Offered
11.6.3 Azenta Life Sciences AAV Plasmid Revenue, Gross Margin and Market Share (2019-2024)
11.6.4 Azenta Life Sciences Main Business Overview
11.6.5 Azenta Life Sciences Latest Developments
11.7 Sartorius
11.7.1 Sartorius Company Information
11.7.2 Sartorius AAV Plasmid Product Offered
11.7.3 Sartorius AAV Plasmid Revenue, Gross Margin and Market Share (2019-2024)
11.7.4 Sartorius Main Business Overview
11.7.5 Sartorius Latest Developments
11.8 Aldevron
11.8.1 Aldevron Company Information
11.8.2 Aldevron AAV Plasmid Product Offered
11.8.3 Aldevron AAV Plasmid Revenue, Gross Margin and Market Share (2019-2024)
11.8.4 Aldevron Main Business Overview
11.8.5 Aldevron Latest Developments
11.9 Omega Bio Tek
11.9.1 Omega Bio Tek Company Information
11.9.2 Omega Bio Tek AAV Plasmid Product Offered
11.9.3 Omega Bio Tek AAV Plasmid Revenue, Gross Margin and Market Share (2019-2024)
11.9.4 Omega Bio Tek Main Business Overview
11.9.5 Omega Bio Tek Latest Developments
11.10 Addgene
11.10.1 Addgene Company Information
11.10.2 Addgene AAV Plasmid Product Offered
11.10.3 Addgene AAV Plasmid Revenue, Gross Margin and Market Share (2019-2024)
11.10.4 Addgene Main Business Overview
11.10.5 Addgene Latest Developments
11.11 Viral Vector Core
11.11.1 Viral Vector Core Company Information
11.11.2 Viral Vector Core AAV Plasmid Product Offered
11.11.3 Viral Vector Core AAV Plasmid Revenue, Gross Margin and Market Share (2019-2024)
11.11.4 Viral Vector Core Main Business Overview
11.11.5 Viral Vector Core Latest Developments
11.12 Azenta
11.12.1 Azenta Company Information
11.12.2 Azenta AAV Plasmid Product Offered
11.12.3 Azenta AAV Plasmid Revenue, Gross Margin and Market Share (2019-2024)
11.12.4 Azenta Main Business Overview
11.12.5 Azenta Latest Developments
11.13 OXGENE
11.13.1 OXGENE Company Information
11.13.2 OXGENE AAV Plasmid Product Offered
11.13.3 OXGENE AAV Plasmid Revenue, Gross Margin and Market Share (2019-2024)
11.13.4 OXGENE Main Business Overview
11.13.5 OXGENE Latest Developments
12 Research Findings and Conclusion

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂